Sino Biopharmaceutical Limited 的流動比率為 1.95,淨利潤率為 12.12,每股銷售為 $1.57。
Star 8 Corp 的收入按細分市場或地理位置如何劃分?
Sino Biopharmaceutical Limited 最大收入來源為 Modernised Chinese Medicines and Chemical Medicines,在最近的收益報告中收入為 30,858,886,510。就地區而言,China 是 Sino Biopharmaceutical Limited 的主要市場,收入為 31,297,379,178。
Star8 Corp., through its subsidiaries, operates as an electric vehicle motorcycle company. The company is headquartered in Miami, Florida. The company went IPO on 2005-07-18. The Company’s subsidiaries include Scarponi Motorcycles and TOMAHAWK Technologies.